SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-034780
Filing Date
2020-12-21
Accepted
2020-12-21 20:00:07
Documents
2
Period of Report
2020-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6121
2 EX-24 DOCUMENT attachment1.htm EX-24 4668
  Complete submission text file 0000899243-20-034780.txt   12180
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Lefebvre Eric (Reporting) CIK: 0001614741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 201405803

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations